Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 730

1.

Factors associated with patient-reported likelihood of using online self-care interventions: a Scleroderma Patient-centered Intervention Network (SPIN) ohort study.

Kwakkenbos L, Cumin J, Carrier ME, Bartlett SJ, Malcarne VL, Mouthon L, Nielson WR, Rannou F, Welling J, Thombs BD; SPIN Investigators.

BMJ Open. 2019 Oct 14;9(10):e029542. doi: 10.1136/bmjopen-2019-029542.

2.

Safety of Primary Thromboprophylaxis Using Apixaban in Ambulatory Cancer Patients with Intracranial Metastatic Disease or Primary Brain Tumors.

Miranda S, Benhamou Y, Wells P, Carrier M.

Thromb Haemost. 2019 Oct 10. doi: 10.1055/s-0039-1695769. [Epub ahead of print] No abstract available.

PMID:
31600806
3.

Physiology of Microglia.

Tay TL, Carrier M, Tremblay MÈ.

Adv Exp Med Biol. 2019;1175:129-148. doi: 10.1007/978-981-13-9913-8_6. Review.

PMID:
31583587
4.

Safety of using direct oral anticoagulants in the diagnostic workup of outpatients with suspicion of acute venous thromboembolism.

Stephen MS, Castellucci LA, Carrier M, Duffett L, Le Gal G, Rodger M, Wells PS, Delluc A.

Haematologica. 2019 Oct 3. pii: haematol.2019.232884. doi: 10.3324/haematol.2019.232884. [Epub ahead of print]

5.

A fully automated pipeline for mining abdominal aortic aneurysm using image segmentation.

Lareyre F, Adam C, Carrier M, Dommerc C, Mialhe C, Raffort J.

Sci Rep. 2019 Sep 24;9(1):13750. doi: 10.1038/s41598-019-50251-8.

6.

Association of recreational drug consumption, cardiac toxicity and heart transplantation

Carrier M, Giraldeau, G, Parent MC, Ducharme A.

Can J Surg. 2019 Oct 1;62(5):356-357.

7.

Anticoagulation for Subsegmental Pulmonary Embolism.

Fernandes A, Connors JM, Carrier M.

N Engl J Med. 2019 Sep 19;381(12):1171-1174. doi: 10.1056/NEJMclde1907665. No abstract available.

PMID:
31532966
8.

Reasons for not participating in scleroderma patient support groups: a comparison of results from the North American and European scleroderma support group surveys.

Kwakkenbos L, Carboni-Jiménez A, Carrier ME, Pépin M, Peláez S, Malcarne VL, El-Baalbaki G, Thombs BD; Scleroderma Patient-centered Intervention Network Support Group Project Advisory Team.

Disabil Rehabil. 2019 Sep 14:1-8. doi: 10.1080/09638288.2019.1656292. [Epub ahead of print]

PMID:
31522575
9.

Higher Drug Prices from Anticompetitive Conduct: Three Case Studies.

Carrier MA.

J Leg Med. 2019 Apr-Jun;39(2):151-167. doi: 10.1080/01947648.2019.1645540.

PMID:
31503532
10.

Utility of FDG-PET/CT for the Detection and Characterization of Sternal Wound Infection Following Sternotomy.

Hariri H, Tan S, Martineau P, Lamarche Y, Carrier M, Finnerty V, Authier S, Harel F, Pelletier-Galarneau M.

Nucl Med Mol Imaging. 2019 Aug;53(4):253-262. doi: 10.1007/s13139-019-00599-6. Epub 2019 Jun 14.

PMID:
31456858
11.

Direct oral anticoagulant for the prevention of thrombosis in ambulatory patients with cancer: A systematic review and meta-analysis.

Li A, Kuderer NM, Garcia DA, Khorana AA, Wells PS, Carrier M, Lyman GH.

J Thromb Haemost. 2019 Aug 17. doi: 10.1111/jth.14613. [Epub ahead of print]

PMID:
31420937
12.

Morphology of Microglia Across Contexts of Health and Disease.

Savage JC, Carrier M, Tremblay MÈ.

Methods Mol Biol. 2019;2034:13-26. doi: 10.1007/978-1-4939-9658-2_2.

PMID:
31392674
13.

Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant.

Douketis JD, Spyropoulos AC, Duncan J, Carrier M, Le Gal G, Tafur AJ, Vanassche T, Verhamme P, Shivakumar S, Gross PL, Lee AYY, Yeo E, Solymoss S, Kassis J, Le Templier G, Kowalski S, Blostein M, Shah V, MacKay E, Wu C, Clark NP, Bates SM, Spencer FA, Arnaoutoglou E, Coppens M, Arnold DM, Caprini JA, Li N, Moffat KA, Syed S, Schulman S.

JAMA Intern Med. 2019 Aug 5. doi: 10.1001/jamainternmed.2019.2431. [Epub ahead of print]

PMID:
31380891
14.

Venous thromboembolism and transfusion after major abdominopelvic surgery.

McAlpine K, Breau RH, Knee C, Carrier M, Violette PD, van Walraven C, McIsaac DI, Mallick R, Cagiannos I, Morash C, Lavallée LT.

Surgery. 2019 Jul 31. pii: S0039-6060(19)30337-X. doi: 10.1016/j.surg.2019.05.050. [Epub ahead of print]

PMID:
31377000
15.

The use of direct oral anticoagulants for primary thromboprophylaxis in ambulatory cancer patients: Guidance from the SSC of the ISTH.

Wang TF, Zwicker JI, Ay C, Pabinger I, Falanga A, Antic D, Noble S, Khorana AA, Carrier M, Meyer G.

J Thromb Haemost. 2019 Oct;17(10):1772-1778. doi: 10.1111/jth.14564. Epub 2019 Jul 28. No abstract available.

PMID:
31353841
16.

Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis.

Khan F, Rahman A, Carrier M, Kearon C, Weitz JI, Schulman S, Couturaud F, Eichinger S, Kyrle PA, Becattini C, Agnelli G, Brighton TA, Lensing AWA, Prins MH, Sabri E, Hutton B, Pinede L, Cushman M, Palareti G, Wells GA, Prandoni P, Büller HR, Rodger MA; MARVELOUS Collaborators.

BMJ. 2019 Jul 24;366:l4363. doi: 10.1136/bmj.l4363.

17.

Sutureless and Transcatheter Aortic Valve Replacement: When Rivals Become Allies.

Ellouze M, Mazine A, Carrier M, Bouchard D.

Semin Thorac Cardiovasc Surg. 2019 Jul 19. pii: S1043-0679(19)30192-3. doi: 10.1053/j.semtcvs.2019.07.003. [Epub ahead of print]

PMID:
31330180
18.

Treatment of Venous Thromboembolism in Cancer. Historical Perspective and Evolving Role of the Direct Oral Anticoagulants.

Carrier M, Soff G, Le Gal G.

Cancer Treat Res. 2019;179:103-115. doi: 10.1007/978-3-030-20315-3_7.

PMID:
31317483
19.

Management of suspected and confirmed recurrent venous thrombosis while on anticoagulant therapy. What next?

Rodger MA, Miranda S, Delluc A, Carrier M.

Thromb Res. 2019 Aug;180:105-109. doi: 10.1016/j.thromres.2019.06.017. Epub 2019 Jun 26. Review.

20.

Accuracy of the Ottawa score in risk stratification of recurrent venous thromboembolism in patients with cancer-associated venous thromboembolism. A systematic review and meta-analysis.

Delluc A, Miranda S, den Exter P, Louzada M, Alatri A, Ahn S, Monreal M, Khorana A, Huisman MV, Wells PS, Carrier M.

Haematologica. 2019 Jul 4. pii: haematol.2019.222828. doi: 10.3324/haematol.2019.222828. [Epub ahead of print]

21.

Extended treatment with edoxaban in cancer patients with venous thromboembolism: A post-hoc analysis of the Hokusai-VTE Cancer study.

Di Nisio M, van Es N, Carrier M, Wang TF, Garcia D, Segers A, Weitz J, Buller H, Raskob G.

J Thromb Haemost. 2019 Jul 4. doi: 10.1111/jth.14561. [Epub ahead of print]

PMID:
31271705
22.

Development of Protein-Like Reference Material for Semiquantitatively Monitoring Visible Proteinaceous Particles in Biopharmaceuticals.

Telikepalli S, Gonzalez K, Dragulin-Otto S, Ripple D, Carrier M, Khan M.

PDA J Pharm Sci Technol. 2019 Sep-Oct;73(5):418-432. doi: 10.5731/pdajpst.2018.008953. Epub 2019 Jun 17.

PMID:
31209163
23.

Anticoagulation of cancer patients with non-valvular atrial fibrillation receiving chemotherapy: Guidance from the SSC of the ISTH.

Delluc A, Wang TF, Yap ES, Ay C, Schaefer J, Carrier M, Noble S.

J Thromb Haemost. 2019 Aug;17(8):1247-1252. doi: 10.1111/jth.14478. Epub 2019 Jun 17. No abstract available.

PMID:
31207027
24.

Microglia along sex lines: From brain colonization, maturation and function, to implication in neurodevelopmental disorders.

Bordeleau M, Carrier M, Luheshi GN, Tremblay MÈ.

Semin Cell Dev Biol. 2019 Oct;94:152-163. doi: 10.1016/j.semcdb.2019.06.001. Epub 2019 Jun 22. Review.

PMID:
31201858
25.

Knockdown of angiopoietin-like 2 induces clearance of vascular endothelial senescent cells by apoptosis, promotes endothelial repair and slows atherogenesis in mice.

Caland L, Labbé P, Mamarbachi M, Villeneuve L, Ferbeyre G, Noly PE, Carrier M, Thorin-Trescases N, Thorin É.

Aging (Albany NY). 2019 Jun 11;11(11):3832-3850. doi: 10.18632/aging.102020.

27.

Performance of the Patient-Reported Outcomes Measurement Information System-29 in scleroderma: a Scleroderma Patient-centered Intervention Network Cohort Study.

Kwakkenbos L, Thombs BD, Khanna D, Carrier ME, Baron M, Furst DE, Gottesman K, van den Hoogen F, Malcarne VL, Mayes MD, Mouthon L, Nielson WR, Poiraudeau S, Riggs R, Sauvé M, Wigley F, Hudson M, Bartlett SJ.

Rheumatology (Oxford). 2019 Jun 5. pii: kez234. doi: 10.1093/rheumatology/kez234. [Epub ahead of print] No abstract available.

PMID:
31168593
28.

Preventing Venous Thromboembolism in Patients with Cancer. Reply.

Carrier M, Le Gal G, Wells PS.

N Engl J Med. 2019 May 30;380(22):2181. doi: 10.1056/NEJMc1904003. No abstract available.

PMID:
31141645
29.

Just the facts: Management of life-threatening bleeding with oral anticoagulant use in the emergency department.

Ho ML, Carrier M.

CJEM. 2019 Jul;21(4):460-463. doi: 10.1017/cem.2019.345. Epub 2019 May 14. No abstract available.

PMID:
31084649
30.

A clinical predictive model for post-hospitalisation venous thromboembolism in patients with inflammatory bowel disease.

McCurdy JD, Israel A, Hasan M, Weng R, Mallick R, Ramsay T, Carrier M.

Aliment Pharmacol Ther. 2019 Jun;49(12):1493-1501. doi: 10.1111/apt.15286. Epub 2019 May 8.

PMID:
31066471
31.

Physical or Occupational Therapy Use in Systemic Sclerosis: A Scleroderma Patient-centered Intervention Network Cohort Study.

Becetti K, Kwakkenbos L, Carrier ME, Gordon JK, Nguyen JT, Mancuso CA, Mouthon L, Nguyen C, Rannou F, Welling J, Thombs BD, Spiera RF; SPIN Investigators.

J Rheumatol. 2019 May 1. pii: jrheum.181130. doi: 10.3899/jrheum.181130. [Epub ahead of print]

PMID:
31043542
32.

Periprocedural interruption of anticoagulation in patients with cancer-associated venous thromboembolism: An analysis of thrombotic and bleeding outcomes.

Shaw JR, Douketis J, Le Gal G, Carrier M.

J Thromb Haemost. 2019 Jul;17(7):1171-1178. doi: 10.1111/jth.14468. Epub 2019 May 29.

PMID:
31038838
33.

Commentary: From primary graft dysfunction to delayed graft function after heart transplantation with veno-arterial extracorporeal membrane oxygenation: A life-saving approach!

Carrier M, Lamarche Y.

J Thorac Cardiovasc Surg. 2019 Apr 4. pii: S0022-5223(19)30766-4. doi: 10.1016/j.jtcvs.2019.03.084. [Epub ahead of print] No abstract available.

PMID:
31029447
34.

A new tool to assess frailty.

Carrier M.

J Thorac Cardiovasc Surg. 2019 Aug;158(2):e45. doi: 10.1016/j.jtcvs.2019.03.002. Epub 2019 Apr 13. No abstract available.

PMID:
30992209
35.

Commentary: Timing for heart transplant after left ventricular assist device implantation-There is no secret recipe!

Carrier M, Lamarche Y.

J Thorac Cardiovasc Surg. 2019 Jun;157(6):2327. doi: 10.1016/j.jtcvs.2019.01.043. Epub 2019 Jan 22. No abstract available.

PMID:
30981526
36.

Efficacy and safety of Xa inhibitors for the treatment of cancer-associated venous thromboembolism.

Kimpton M, Carrier M.

Expert Opin Drug Saf. 2019 Apr;18(4):313-320. doi: 10.1080/14740338.2019.1601699. Epub 2019 Apr 8. Review.

PMID:
30925842
37.

Implanted vascular access device related deep vein thrombosis in oncology patients: A prospective cohort study.

Suleman A, Jarvis V, Hadziomerovic A, Carrier M, McDiarmid S.

Thromb Res. 2019 May;177:117-121. doi: 10.1016/j.thromres.2019.02.033. Epub 2019 Mar 6.

38.

Low-molecular-weight-heparin versus a coumarin for the prevention of recurrent venous thromboembolism in high- and low-risk patients with active cancer: a post hoc analysis of the CLOT Study.

Woodruff S, Lee AYY, Carrier M, Feugère G, Abreu P, Heissler J.

J Thromb Thrombolysis. 2019 May;47(4):495-504. doi: 10.1007/s11239-019-01833-w.

39.

Shortening patient-reported outcome measures through optimal test assembly: application to the Social Appearance Anxiety Scale in the Scleroderma Patient-centered Intervention Network Cohort.

Harel D, Mills SD, Kwakkenbos L, Carrier ME, Nielsen K, Portales A, Bartlett SJ, Malcarne VL, Thombs BD; SPIN Investigators.

BMJ Open. 2019 Feb 22;9(2):e024010. doi: 10.1136/bmjopen-2018-024010.

40.

Relationship between type of unprovoked venous thromboembolism and cancer location: An individual patient data meta-analysis.

Jara-Palomares L, van Es N, Praena-Fernandez JM, Le Gal G, Otten HM, Robin P, Piccioli A, Lecumberri R, Religa P, Rieu V, Rondina M, Beckers M, Prandoni P, Salaun PY, Di Nisio M, Bossuyt PM, Kraaijpoel N, Büller HR, Carrier M.

Thromb Res. 2019 Apr;176:79-84. doi: 10.1016/j.thromres.2019.02.011. Epub 2019 Feb 13.

PMID:
30780008
41.

Reduction of plasma angiopoietin-like 2 after cardiac surgery is related to tissue inflammation and senescence status of patients.

Noly PE, Labbé P, Thorin-Trescases N, Fortier A, Nguyen A, Thorin E, Carrier M.

J Thorac Cardiovasc Surg. 2019 Sep;158(3):792-802.e5. doi: 10.1016/j.jtcvs.2018.12.047. Epub 2019 Jan 8.

PMID:
30745045
42.

Thromboembolic disease in palliative and end-of-life care: A narrative review.

Chin-Yee N, Tanuseputro P, Carrier M, Noble S.

Thromb Res. 2019 Mar;175:84-89. doi: 10.1016/j.thromres.2018.12.028. Epub 2019 Jan 3. Review.

PMID:
30731388
43.

Treatment of Superficial Vein Thrombosis: A Systematic Review and Meta-Analysis.

Duffett L, Kearon C, Rodger M, Carrier M.

Thromb Haemost. 2019 Mar;119(3):479-489. doi: 10.1055/s-0039-1677793. Epub 2019 Feb 4.

PMID:
30716777
44.

Challenges and support service preferences of informal caregivers of people with systemic sclerosis: a cross-sectional survey.

Rice DB, Cañedo-Ayala M, Carboni-Jiménez A, Carrier ME, Cumin J, Malcarne VL, Hagedoorn M, Thombs BD; Scleroderma Caregiver Advisory Team.

Disabil Rehabil. 2019 Jan 29:1-7. doi: 10.1080/09638288.2018.1557268. [Epub ahead of print]

PMID:
30696293
45.

Extended thromboprophylaxis with low-molecular weight heparin (LMWH) following abdominopelvic cancer surgery.

Carrier M, Altman AD, Blais N, Diamantouros A, McLeod D, Moodley U, Nguyen C, Young S, Schwenter F.

Am J Surg. 2019 Sep;218(3):537-550. doi: 10.1016/j.amjsurg.2018.11.046. Epub 2018 Dec 16.

PMID:
30595331
46.

On the Prowl: An In Vivo Method to Identify RNA Partners of a sRNA.

Carrier MC, Morin C, Massé E.

Methods Enzymol. 2018;612:251-268. doi: 10.1016/bs.mie.2018.09.006. Epub 2018 Oct 8.

PMID:
30502945
47.

Apixaban to Prevent Venous Thromboembolism in Patients with Cancer.

Carrier M, Abou-Nassar K, Mallick R, Tagalakis V, Shivakumar S, Schattner A, Kuruvilla P, Hill D, Spadafora S, Marquis K, Trinkaus M, Tomiak A, Lee AYY, Gross PL, Lazo-Langner A, El-Maraghi R, Goss G, Le Gal G, Stewart D, Ramsay T, Rodger M, Witham D, Wells PS; AVERT Investigators.

N Engl J Med. 2019 Feb 21;380(8):711-719. doi: 10.1056/NEJMoa1814468. Epub 2018 Dec 4.

PMID:
30511879
48.

Residual pulmonary vascular obstruction and recurrence after acute pulmonary embolism: protocol for a systematic review and meta-analysis of individual participant data.

Robin P, Eddy M, Sikora L, Le Roux PY, Carrier M, Couturaud F, Planquette B, Pesavento R, Rodger M, Salaun PY, Le Gal G.

BMJ Open. 2018 Nov 28;8(11):e023939. doi: 10.1136/bmjopen-2018-023939.

49.

How I treat cancer-associated venous thromboembolism.

Kraaijpoel N, Carrier M.

Blood. 2019 Jan 24;133(4):291-298. doi: 10.1182/blood-2018-08-835595. Epub 2018 Nov 26.

PMID:
30478093
50.

Treatment algorithm in cancer-associated thrombosis: Canadian expert consensus.

Carrier M, Blais N, Crowther M, Kavan P, Le Gal G, Moodley O, Shivakumar S, Tagalakis V, Wu C, Lee AYY.

Curr Oncol. 2018 Oct;25(5):329-337. doi: 10.3747/co.25.4266. Epub 2018 Oct 31.

Supplemental Content

Loading ...
Support Center